The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones

References

1. ↵
   1. Siegel R,
   2. DeSantis C,
   3. Jemal A

   (2014) Colorectal cancer statistics, 2014. CA: A Cancer Journal for Clinician 64:104–117.

   OpenUrl
2. ↵
   1. Al-Eid YS,
   2. Manalo MS,
   3. Bazarbashi S

   (2010) Cancer Incidence Report Saudi Arabia 2010. [Database on the Internet]. Available from URL: http://www.chs.gov.sa/Ar/mediacenter/NewsLetter/2010%20Report%20(1).pdf. cited 2013 Feb 5.
3. ↵
   1. Sieber PR,
   2. Rommel FM,
   3. Theodoran CG,
   4. Hong RD,
   5. Del Terzo MA

   (2007) Contemporary Prostate Biopsy Complication Rates in Community-Based Urology Practice. Urology 70:498–500.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Nam RK,
   2. Saskin R,
   3. Lee Y,
   4. Liu Y,
   5. Law C,
   6. Klotz LH,
   7. et al.

   (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–968.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Raaijmakers R,
   2. Kirkels WJ,
   3. Roobol MJ,
   4. Wildhagen MF,
   5. Schrder FH

   (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826–830.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Feliciano J,
   2. Teper E,
   3. Ferrandino M,
   4. Macchia R,
   5. Blank W,
   6. Grunberger I,
   7. et al.

   (2008) The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J Urol 179:952–955.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Carignan A,
   2. Roussy JF,
   3. Lapointe V,
   4. Valiquette L,
   5. Sabbagh R,
   6. Pépin J

   (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62:453–459.

   OpenUrlCrossRefPubMed
8. 1. Loeb S,
   2. Carter HB,
   3. Berndt SI,
   4. Ricker W,
   5. Schaeffer EM

   (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186:1830–1834.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Young JL,
   2. Liss MA,
   3. Szabo RJ

   (2009) Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 74:332–338.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Urban JA

    (2006) Cost analysis of surgical site infections. Surg Infect (Larchmt) 7(Suppl 1):S19–S22.

    OpenUrl
11. ↵
    1. Adibi M,
    2. Pearle MS,
    3. Lotan Y

    (2012) Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. BJU Int 110(2 Pt 2):E86–E91.

    OpenUrlPubMed
12. ↵
    1. Sanders A,
    2. Buchan N

    (2013) Infection-related hospital admissions after transrectal biopsy of the prostate. ANZ J Surg 83:246–248.

    OpenUrl
13. 1. Liss MA,
    2. Chang A,
    3. Santos R,
    4. Nakama-Peeples A,
    5. Peterson EM,
    6. Osann K,
    7. et al.

    (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185:1283–1288.

    OpenUrlCrossRefPubMedWeb of Science
14. 1. Yezli S,
    2. Shibl AM,
    3. Livermore DM,
    4. Memish ZA

    (2014) Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia. J Chemother 26:257–272.

    OpenUrlCrossRefPubMed
15. ↵
    1. Anderson E,
    2. Leahy O,
    3. Cheng AC,
    4. Grummet J

    (2015) Risk factors for infection following prostate biopsy - a case control study. BMC Infect Dis 15:580.

    OpenUrlCrossRefPubMed
16. ↵
    1. Emeka PM,
    2. Al-Omar M,
    3. Khan TM

    (2014) Public attitude and justification to purchase antibiotics in the Eastern region Al Ahsa of Saudi Arabia. Saudi Pharm J 22:550–554.

    OpenUrl
17. ↵
    1. Belkina T,
    2. Al Warafi A,
    3. Eltom H,
    4. Tadjieva N,
    5. Kubena A,
    6. Vlcek J

    (2014) Antibiotic use and knowledge in the community of Yemen, Saudi Arabia, and Uzbekistan. J Infect Dev Ctries 8:424–429.

    OpenUrlPubMed
18. ↵
    1. Altalhi AD,
    2. Gherbawy YA,
    3. Hassan SA

    (2010) Antibiotic resistance in Escherichia coli isolated from retail raw chicken meat in Taif, Saudi Arabia. Foodborne Pathog Dis 7:281–285.

    OpenUrlCrossRefPubMed